Abstract: Adequate diagnosis of upper urinary tract (UUT) tumors is essential for successful local treatment. Organsparing approaches are technically di cult and require consistent further development. Appropriate models for investigating new diagnostic and therapeutic methods are not yet available. This study demonstrates the incorporation of a fresh sample model into ve di erent test levels (I-V) for improving the diagnosis and therapy of ureteral tumors. In these test levels, new diagnostic and ablation techniques are evaluated for feasibility, application safety, e cacy and accuracy. An assessment of their suitability for broad preclinical and clinical application also took economic aspects into account.
Introduction
Adequate diagnosis of upper urinary tract (UUT) tumors is essential for successful local treatment and organ preservation. Due to the existing diagnostic uncertainty, many patients with ureteral (UR) tumors are still overtreated, which means they undergo nephroureterectomy. Nephrectomy involves dialysis at worst. Conventional imaging (magnetic resonance tomography, computed tomography, extracorporeal ultrasound) are still limited in terms of resolution and diagnostic adequacy [1] . However, diagnostic uncertainty is only part of the problem. Organ-sparing interventions in the upper urinary tract (UUT) are technically di cult and also require consistent further development. There is still a lack of appropriate models for evaluating new diagnostic and therapeutic procedures as well as practical training in their endourological application [2, 3] . This study demonstrates the incorporation of a fresh sample model, developed according to the identi ed demands, into the respective test levels: I -"Endourological model-UUT", II -"Intraureteral ultrasound (IUUS)", III -"Intraureteral laser therapy (IULT)", IV -"First in men -safety/feasibility (IUUS/IULT)", and V -"First in men -accuracy/e cacy (IUUS/IULT)". An assessment of their suitability for broad preclinical and clinical application also took economic aspects into account.
Material and methods . Level I: endourological model-UUT
Aim: Development and production of a multifunctional endourological and practice-equivalent training model (Figure 1 ). Material: Transparent gel box for holding fresh samples (nephroureteral model "Deutsches Landschwein"), with two hydrogel phases for in situ simulation. The standard endourological instruments (Carl Storz, Tuttlingen, Germany; Uroskop Omnia, Siemens, Erlangen, Germany) and the validated questionnaire "Objective Structured Assessment of Technical Skills (OSATS)" were used to evaluate 15 surgeons in 3 groups with di erent training levels [4] . Methods: Three training blocks (OSATS and intervention time) were evaluated in the model before and after training (specialist instructions, 60 minutes): 1. Contrast-enhanced imaging of the ureter (UR) and pelvicalyceal system (PCS), placement of a safety wire and rigid ureterorenoscopy (rURS). 2. Placement of a sluice in the renal pelvis via wire, complete inspection of the PCS with a exible ureterorenoscope (fURS). 3. Disintegration of a kidney stone by laser and removal of 2 concrements (Figure 3) . Charr., Coloplast, Hamburg, Germany), standard urological instruments. Methods: To exclude in ltration, 5 patients with con rmed urothelial carcinoma in the UUT underwent IUUS as well as the standard diagnostic procedure in order to provide legitimation for an "individual curative attempt". After con rmation, conservative IULT was performed using the Limmer Laser and Harpoon Fiber. 
. Level II: intraureteral ultrasound (IUUS)
Aim
Results and discussion . Level I: endourological model -UUT
Result: In its production and application, the "endourological model-UUT" proved to be an inexpensive, simple and robust experimental setup that easily enabled stepwise evaluation of test subjects. Functionality for at least 2 days could be ensured when using fresh samples. It was assessed by all test subjects and evaluators as suitable for the subsequently planned examinations (Level II and III). The OSATS evaluation before and after training in the model revealed marked improvement in the required skills. Discussion: Available training models for the UUT are expensive and impractical [2, 3] . The "endourological model -UUT" enabled practical training in a typical endourological setting. Marked shortening of the learning curve was detectable (Figure 4 ). Technical improvements without great e ort or expense are planned. A limiting factor was the absence of blood ow and respiratory movement in the model.
. Level II: intraureteral ultrasound (IUUS)
Result: With the "endourological model-UUT" modi ed by test specimens, IUUS examinations could be performed for all US catheters in a robust and standardized manner (automatic US catheter pullback: 1mm/s, 15fps). The investigation focused on visualization of the urothelium and the adjacent muscle layer. Subjectively, the UR wall layers could be distinguished most precisely with the US catheter "Eagle Eye® Platinum ST". Its US images were therefore used for histological comparison. The test specimens could be visualized in the UR surroundings in relation to device settings/catheter ( Figure 5 ). Discussion: Our results suggest that therapeutically relevant tumor in ltrations of these layers can probably be visualized in the human UR; an investigation in a clinical setting should therefore be performed in Levels IV and V. Various study groups have already examined other intraluminal US catheters in a preclinical and clinical setting [7, 8] . Due to the small number of cases, the assessment of suitability for clinical application remained open.
. Level III: intraureteral laser therapy (IULT)
Result: In the "endourological model-UUT", IULT could be performed easily for de ned energy levels (3, 10, 15, 20 watts). Laser ablation restricted to the urothelial layer succeeded subjectively with 3W. Ablations of solid tumors (5-10 mm) required 10-15W. At 20W, dosed energy output for targeted ablation was complicated (adhesions). Temperature elevations measured at the outer surface of the UR during local laser applications remained below the denaturation level (15 W, 980nm, continuous mode). Discussion: The application of laser energy with an angled Harpoon Laser tip enables subtle tissue ablation. Comparative studies of other laser types describe acceptable side e ects (SE) [11] . Subjectively improved SE in our examinations therefore enabled application in a clinical setting in Levels IV/V.
. Level IV: rst in men-safety/feasibility (IUUS/IULT)
Result: As expected, IVUS catheter placement for IUUS succeeded easily in an endourological setting when applied in humans (5 patients) owing to the catheter dimensions and application similarity (intravascularintraureteral). Visualization of the wall layers succeeded subjectively better than in the "endourological model-UUT"; in ltration of the muscle layer could be excluded in both the IUUS and the standard biopsy (Bx)/urine cytology. Local tumor lasering was therefore carried out using the Limmer Laser (Harpoon Fiber, Ř 400 µm). Papillary tumors up to 5mm could be ablated very precisely to the muscle level of the UR (3 W, 980 nm, continuous mode). There was no intraoperative damage to surroundings. Solid ndings (5-10 mm) required higher energy levels (10-15W, 980nm, continuous mode, pulsed mode) for complete ablation. The angled laser tip (30°) enables very precise layerwise ablation of tumor tissue in both continuous and pulsed mode. Both IUUS and IULT proved to be simple and safe methods for human application. The actual e cacy (tumor ablation) and accuracy (damage to surroundings) of the two methods should be established in the recommended standard endourological follow-ups (Level V). Discussion: Placement of the IVUS catheter in an IUUS setting does not di er from typical endourological procedures, and the better spatial resolution enabled a more detailed diagnosis than that achieved with currently recommended imaging. Various study groups have already tested other intraluminal US catheters (30MHz, 5F, B-mode; 12.5/20MHz, 6.2F) for detailed diagnosis of UR tumors [7, 8] . IULT management and ablation behavior made it possible to ablate even larger tumors with simultaneous hemostasis and no collateral damage. The applied 400 µm laser ber permitted controlled exion of the fURS for lasering lower calices. The angled laser tip o ers marked advantages over other commercially available systems [5, 6] .
. Level V: rst in men-accuracy/e cacy (IUUS/IULT)
Result: The endourological follow-ups 8-12 weeks after the primary intervention (IUUS, IULT) showed good tumor control in all patients. Small papillary ndings had disappeared completely in the optically regenerated urothelial layer. After lasering several large (5-10 mm) solid ndings, two small residual solid tumors were seen in 1 case. Reexamination for possible in ltration into deeper wall layers after standard Bx/urine cytology and IUUS remained negative. The residual ndings were again submitted to IULT with the Limmer Laser (Harpoon Fiber, Ř 400 µm, 3-10W, 980nm, continuous mode, pulsed mode). This patient was also tumor-free after another 8 weeks. Imaging of the wall layers also succeeded subjectively better after primary therapy (IULT) than in the "endourological model-UUT". Both IUUS and IULT proved to be accurate and e ective in tumor therapy. The "third look" disclosed no evidence of damage to surroundings. Discussion: Investigations on the long-term follow-up of laser-treated UR tumors are rare [9, 10] . Guidelines for IUUS diagnosis are lacking, and they are vague for IULT due to a lack of data [1] . With strict indications, good tumor control with organ preservation could be achieved in our cohorts (Figure 6) . Side e ects did not occur and are also assessed as minimal in the literature [11] . Limiting factors were the small number of patients and the short follow-up.
Conclusion
Our endourological model-UUT can be safely and e ectively used as a training tool to shorten learning curves. Endourological techniques and conservative tumor treatment in the upper urinary tract is an evolving eld and can be successfully used as rst-line treatment for UUT tumors in selected patients. Recent technical advancements should now be consistently investigated and standardized with regard to diagnosis and therapy.
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